Pay in 4 interest-free payments of $6.17 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
Sharps container for safe needle disposal
B.Jevtovic-TodorovicV
Clinical trial data by dose The SURMOUNT-1 trial, the landmark study that led to Zepbound FDA approval, enrolled 2,539 adults with obesity or overweight with at least one weight-related condition
Our program pairs GLP-1 medication with personalized one-on-one coaching and continuous support to help you achieve and sustain your weight loss goals
Manufacturer savings programs Both Novo Nordisk (maker of Wegovy and Ozempic) and Eli Lilly (maker of Zepbound and Mounjaro) offer savings programs that can reduce out-of-pocket costs for eligible patients
US$ 29.42
US$ 23.25
US$ 24.30
US$ 25.78
US$ 28.07
US$ 23.89
US$ 25.95
US$ 29.80
US$ 23.39
US$ 26.52
